Small-scale systems for in vivo drug delivery

Nature Biotechnology

Volumn 21, Issue 10, 2003, Pages 1184-1191

  LaVan, David A ^a   McGuire, Terry ^b   Langer, Robert ^c  

^a Yale University   (United States)

^b Polaris Venture Partners   (United States)

^c Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; MOLECULAR BIOLOGY; NANOTECHNOLOGY;

DRUG DELIVERY;

DRUG DOSAGE;

DIMETICONE; ELASTOMER; LEUPRORELIN; LIPOSOME; NANOPARTICLE; SILVER NITRATE; SULFADIAZINE SILVER; TITANIUM;

AEROSOL; ANALYTIC METHOD; BIOCOMPATIBILITY; DEVICE; DIFFUSION; DIFFUSION CHAMBER; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EVALUATION; IMPLANT; MATERIAL STATE; MOLECULAR INTERACTION; NANOTECHNOLOGY; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; SENSOR;

BIOSENSING TECHNIQUES; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; EQUIPMENT DESIGN; INFUSION PUMPS, IMPLANTABLE; MICROFLUIDICS; MINIATURIZATION; NANOTECHNOLOGY; NANOTUBES;

EID: 0141765877     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt876     Document Type: Review

References (144)

1. Langer, R. New methods of drug delivery. Science 249, 1527-1533 (1990).
2. Reed, M.L. et al. Micromechanical devices for intravascular drug delivery. J. Pharm. Sci. 87, 1387-1394 (1998).
3. Dario, P., Carrozza, M.C., Benvenuto, A. & Menciassi, A. Micro-systems in biomedical applications. J. Micromech. Microeng. 10, 235-244 (2000).
4. Polla, D.L. et al. Microdevices in medicine. Annu. Rev. Biomed. Eng. 2, 551-576 (2000).
5. Lavan, D.A., Lynn, D., M. & Langer, R. Moving smaller in drug discovery and delivery. Nat. Rev. Drug. Discov. 1, 77-84 (2002).
6. Shawgo, R.S., Richards Grayson, A.C., Li, Y. & Cima, M.J. BioMEMS for drug delivery. Curr. Opin. Solid State Mater. Sci. 6, 329-334 (2002).
7. Tao, S.L. & Desai, T.A. Microfabricated drug delivery systems: from particles to pores. Adv. Drug Deliv. Rev. 55, 315-328 (2003).
8. Saltzman, W.M. & Olbricht, W.L. Building drug delivery into tissue engineering. Nat. Rev. Drug Discov. 1, 177-186 (2002).
9. McAllister, D.V., Allen, M.G. & Prausnitz, M.R. Microfabricated microneedles for gene and drug delivery. Annu. Rev. Biomed. Eng. 2, 289-313 (2000).
10. Santini, J.T. Jr., Cima, M.J. & Langer, R. A controlled-release microchip. Nature 397, 335-338 (1999).
11. Maillefer, D., Van Lintel, H., Rey-Mermet, G. & Hirschi, R. A high-performance silicon micropump for an implantable drug delivery system. in 12th IEEE international Conference on Micro Electro Mechanical Systems, Technical Digest, Orlando, Florida, USA, Jan 17-21, 1999 541-546 (IEEE, New York, USA, 1999).
12. Chen, H., Torchilin, V. & Langer, R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. 13. 1378-1383 (1996).
13. Woodley, J. Bioadhesion: new possibilities for drug administration? Clin. Pharmacokinet. 40, 77-84 (2001).
14. Keegan, M.E., Whittum-Hudson, J.A. & Saltzman, M.W. Biomimetic design in microparticulate vaccines. Biomaterials 24, 4435-4443 (2003).
15. Ito, Y., Hu, Z., Yoshikawa, Y., Murakami, M. & Takada, K. Oral bioadhesive patch system for the delivery of peptide/proteins. in Proceedings of the 26th international Symposium on Controlled Release of Bioactive Materials pp. 851-852 (Controlled Release Society, Minneapolis, Minnesota, USA, 1999).
16. Shen, Z. & Mitragotri, S. Intestinal patches for oral drug delivery. Pharm. Res. 19, 391-395 (2002).
17. Tao, S.L., Lubeley, M.W. & Desai, T.A. Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery. J. Control. Release 88, 215-228 (2003).
18. Chen, H. & Langer, R. Magnetically-responsive polymerized liposomes as potential oral delivery vehicles. Pharm. Res. 14, 537-540 (1997).
19. Borenstein, J.T., King, K.R., Terai, H. & Vacanti, J.P. Capillary formation in microfabricated polymer scaffolds. Mater. Res. Soc. Symp. Proc. 711, 163-168 (2002).
20. Unger, M.A., Chou, H.-P., Thorsen, T., Scherer, A. & Quake, S.R. Monolithic microfabricated valves and pumps by multilayer soft lithography. Science 288, 113-116 (2000).
21. Hansen, C.L., Skordalakes, E., Berger, J.M. & Quake, S.R. A robust and scalable microfluidic metering method that allows protein crystal growth by free interface diffusion. Proc. Natl. Acad. Sci. USA 99, 16531-16536 (2002).
22. Xia, Y. & Whitesides, G.M. Soft lithography. Polym. Mater. Sci. Eng. 77, 596-598 (1997).
23. Quake, S.R. & Scherer, A. From micro- to nanofabrication with soft materials. Science 290, 1536-1540 (2000).
24. Wang, Y., Ameer, G.A., Sheppard, B.J. & Langer, R. A tough biodegradable elastomer. Nat. Biotechnol. 20, 602-606 (2002).
25. Manz, A. et al. Micromachining of monocrystalline silicon and glass for chemical analysis systems. A look into next century's technology or just a fashionable craze? Trends Anal. Chem. 10, 144-149 (1991).
26. Harrison, D.J., Manz, A., Fan, Z., Luedi, H. & Widmer, H.M. Capillary electrophoresis and sample injection systems integrated on a planar glass chip. Anal. Chem. 64, 1926-1932 (1992).
27. Goll, C. et al. Microvalves with bistable buckled polymer diaphragms. J. Micromech. Microeng. 6, 77-79 (1996).
28. Schomburg, W.K., Buestgens, B., Fahrenberg, J. & Maas, D. Components for microfluidic handling modules. in Proceedings of μTAS '94: The 1st Workshop on Micro Total Analytical Systems (ed. Bergveld, P.) pp. 255-258 (Kluwer, Dordrecht, The Netherlands, 1995).
29. Ohgawara, H., Hirotani, S., Miyazaki, J. & Teraoka, S. Membrane immunoisolation of a diffusion chamber for bioartificial pancreas. Artif. Organs 22, 788-794 (1998).
30. Colton, C.K. Implantable biohybrid artificial organs. Cell Transplant. 4, 415-436 (1995).
31. Desai, T.A., Chu, W.H., Tu, J., Shrewsbury, P. & Ferrari, M. Microfabricated biocapsules for cell xenografts: a review. Proc. SPIE 2978, 216-226 (1997).
32. Desai, T.A. et al. Microfabricated immunoisolating biocapsules. Biotechnol. Bioeng. 57, 118-120 (1998).
33. Sefton, M.V., Horvath, V. & Zingg, W. Insulin delivery by a diffusion-controlled micropump in pancreatectomized dogs: phase 1. J. Control. Release 12, 1-12 (1990).
34. Atkinson, L.E., Dunn, J.T., Gale, R.M. & Rivera, D.L. Segmented device for simultaneous delivery of multiple beneficial agents. US Patent 5443461 (1995).
35. Hanas, R. Selection for and initiation of continuous subcutaneous insulin infusion. Horm. Res. 57, 101-104 (2002).
36. Damascelli, B. et al. Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump. Cancer 66, 237-241 (1990).
37. Brown, J.N., Miller, J.M., Altschuler, R.A. & Nuttall, A.L. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hearing Res. 70, 167-172 (1993).
38. Gardner, B. et al. Intrathecal baclofen - a multicentre clinical comparison of the Medtronics Programmable, Cordis Secor and Constant Infusion Infusaid drug delivery systems. Paraplegia 33, 551-554 (1995).
39. Blair, M.J. et al. Subconjunctivally implanted micro-osmotic pumps for continuous ocular treatment in horses. Am. J. Veter. Res. 60, 1102-1105 (1999).
40. Fisher, R.S. & Ho, J. Potential new methods for antiepileptic drug delivery. CNS Drugs 16, 579-593 (2002).
41. Diaz, S. et al. A five-year clinical trial of levonorgestrel silastic implants (Norplant tm). Contraception 25, 447-456 (1982).
42. Wright, J.C. et al. A one-year implantable, osmotic delivery system (Duros leuprolide implant) for the treatment of advanced prostate cancer. in Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials 59-60 (Controlled Release Society, Minneapolis, Minnesota, USA, 1997).
43. Ohgawara, H. Strategies for immunoisolation in islet transplantation: challenges for the twenty-first century. J. Hepato-Biliary-Pancreatic Surg. 7, 374-379 (2000).
44. Regulier, E., Schneider, B.L., Deglon, N., Beuzard, Y. & Aebischer, P. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts. Gene Ther. 5, 1014-1022 (1998).
45. Jolley, W.B., Hinshaw, D.B., Call, T.W. & Alvord, L.S. Xenogeneic pancreatic islet transplantation in proteolytic enzyme-bonded diffusion chambers in diabetic rats. Transplant. Proc. 9, 363-365 (1977).
46. Desai, T.A. et al. Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts. Biomed. Microdevices 1, 131-138 (1999).
47. Ogura, H. et al. Implantation of genetically manipulated fibroblasts into mice as antitumor. Alpha-interferon therapy. Cancer Res. 50, 5102-5106 (1990).
48. Brauker, J.H., Geller, R.L., Johnston, W.D., Levon, S.A. & Maryanov, D.A. Implantation of tumor cells for the prevention and treatment of cancer. US Patent 6156305, Cont.-in-part of U.S. Ser. No. 272,189, abandoned (2000).
49. Brauker, J., Martinson, L.A., Young, S.K. & Johnson, R.C. Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization. Transplantation 61, 1671-1677 (1996).
50. Kuhtreiber, W.M., Lanza, R.P., Beyer, A.M., Kirkland, K.S. & Chick, W.L. Relationship between insulin secretion and oxygen tension in hybrid diffusion chambers. ASAIO J. 39, M247-M251 (1993).
51. Vardi, P., Gross, Y., Bloch, K., Bloch, D. & Boukobza, N. Implantable device comprising oxygen generator. PCT International Application 0150983 (2001).
52. Colton, C.K. & Swette, L.L. Method of delivering oxygen to cells by electrolyzing water. US Patent 6368592 (2002).
53. Cohen, H. et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 7, 1896-1905 (2000).
54. Merisko-Liversidge, E. et al. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 13, 272-278 (1996).
55. Gref, R. et al. Biodegradable long-circulating polymer nanospheres. Science 263, 1600-1603 (1994).
56. Akerman, M.E., Chan, W.C.W., Laakkonen, P., Bhatia, S.N. & Ruoslahti, E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA 99, 12617-12621 (2002).
57. Tkachenko Alexander, G. et al. Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J. Am. Chem. Soc. 125, 4700-4701 (2003).
58. Hallahan, D. et al. Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell 3, 63-74 (2003).
59. Edwards, D.A. et al. Large porous particles for pulmonary drug delivery. Science 276, 1868-1871 (1997).
60. Edwards, D.A. & Dunbar, C. Bioengineering of therapeutic aerosols. Annu. Rev. Biomed. Eng. 4, 93-107 (2002).
61. Tsapis, N., Bennett, D., Jackson, B., Weitz, D.A. & Edwards, D.A. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc. Natl. Acad. Sci. USA 99, 12001-12005 (2002).
62. Luo, D. & Saltzman, W.M. Synthetic DNA delivery systems. Nat. Biotechnol. 18, 33-37 (2000).
63. Yang, N.S., Burkholder, J., Roberts, B., Martinell, B. & McCabe, D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87, 9568-9572 (1990).
64. Anderson, W.F. Human gene therapy. Nature 392, 25-30 (1998).
65. Lynn, D.M., Amiji, M.M. & Langer, R. pH-responsive polymer microspheres: rapid release of encapsulated material within the range of intracellular ph. Angew. Chem. Int. Ed. Engl. 40, 1707-1710 (2001).
66. De Jaeghere, F. et al. pH-dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs. AAPS Pharm. Sci. 3, E8 (2001).
67. Choi, J.S., Mackay, J.A. & Szoka, F.C. Jr. Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization. Bioconj. Chem. 14, 420-429 (2003).
68. Hwang, S.J. & Davis, M.E. Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration. Curr. Opin. Mol. Ther. 3, 183-191 (2001).
69. Anderson, D.G., Lynn, D.M. & Langer, R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem. Int. Ed. Engl. 42, 3153-3158 (2003).
70. Lee, M., Rentz, J., Han, S.O., Bull, D.A. & Kim, S.W. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther. 10, 585-593 (2003).
71. Affleck, D.G., Yu, L., Bull, D.A., Bailey, S.H. & Kim, S.W. Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system. Gene Ther. 8, 349-353 (2001).
72. Antibacterial detergent compositions containing heavy metal salts of 2-pyridinethione-1-oxide. British Patent 1111708 (1968).
73. Kazama, T. & Irie, T. Microbicidal thermoplastic composites. Japanese Patent 03273040 (1991).
74. Sasaki, S., Suzuki, K. & Okuma, S. Antibacterial cellulose microparticles. Japanese Patent 04122743 (1992).
75. Stoimenov, P.K., Klinger, R.L., Marchin, G.L. & Klabunde, K.J. Metal oxide nanoparticles as bactericidal agents. Langmuir 18, 6679-6686 (2002).
76. Davenas, J., Thevenard, P., Philippe, F. & Arnaud, M.N. Surface implantation treatments to prevent infection complications in short term devices. Biomolec. Eng. 19, 263-268 (2002).
77. Lee, H.J., Yeo, S.Y. & Jeong, S.H. Antibacterial effect of nanosized silver colloidal solution on textile fabrics. J. Mater. Sci. 38, 2199-2204 (2003).
78. Berger, T.J., Spadaro, J.A., Chapin, S.E. & Becker, R.O. Electrically generated silver ions: quantitative effects on bacterial and mammalian cells. Antimicrob. Agents Chemother. 9, 357-358 (1976).
79. Modak, S.M. & Fox, C.L. Jr. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem. Pharmacol. 22, 2391-2404 (1973).
80. Fox, C.L. Jr., Rappole, B. & Stanford, W. Control of pseudomonas infection in burns by silver sulfadiazine. Surg. Gynecol. Obstet. 128, 1021-1026 (1969).
81. Starodub, M.E. & Trevors, J.T. Silver resistance in Escherichia coli r1. J. Med. Microbiol. 29, 101-110 (1989).
82. Chive, M., Nguyen, D.D. & Leroy, Y. Localized hyperthermia. Towards an atraumatic method of heat control based on microwave thermography (author's translation). Bull. Cancer 68, 293-294 (1981).
83. Marchal, C. et al. Treatment of superficial cancerous tumors by hyperthermia induced by ultrasonics or microwaves. C. R. Seances Soc. Biol. Fil. 177, 358-367 (1983).
84. Pouliquen, D. Magnetite-dextran nanocapsules: preparation and properties. Microspheres Microcapsules Liposomes 3, 495-523 (2001).
85. Lilly, M.B., Brezovich, I.A. & Atkinson, W.J. Hyperthermia induction with thermally self-regulated ferromagnetic implants. Radiology 154, 243-244 (1985).
86. Tucker, R.D., Huidobro, C., Larson,T. & Platz, C.E. Use of permanent interstitial temperature self-regulating rods for ablation of prostate cancer. J. Endourology 14, 511-517 (2000).
87. Arshady, R. Radiolabeled and magnetic microparticles: Introduction and overview. Microspheres Microcapsules Liposomes 3, 1-37 (2001).
88. Hamad-Schifferli, K., Schwartz, J.J., Santos, A.T., Zhang, S. & Jacobson, J.M. Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna. Nature 415, 152-155 (2002).
89. Hamad-Schifferli, K., Schwartz, J.J., Santos, A.T., Zhang, S. & Jacobson, J.M. Direct electronic control of biomolecular systems: using nanocrystals as antennas for regulation of biological activity. in Synthesis, Functional Properties and Applications of Nanostructures. Materials Research Society Symposium Proceedings vol. 676 (eds. Hahn, H.W., Feldheim, D.L., Kubiak, C.P., Tannenbaum, R. & Siegel, R.W.) (Materials Research Society, Warrendale, Pennsylvania, USA, 2001).
90. Miyata, T., Asami, N. & Uragami, T. A reversibly antigen-responsive hydrogel. Nature 399, 766-769 (1999).
91. Wang, C., Stewart, R.J. & Kopecek, J. Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature 397, 417-420 (1999).
92. Nowak, A.P. et al. Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature 417, 424-428 (2002).
93. Kwon, I.C., Bae, Y.H. & Kim, S.W. Electrically erodible polymer gel for controlled release of drugs. Nature 354, 291-293 (1991).
94. Madou, M.J. & He, K.-Q. Exploitation of a novel artificial muscle for controlled drug delivery. Polym. Mater. Sci. Eng. 83, 495-497 (2000).
95. Heller, J. & Trescony, P.V. Controlled drug release by polymer dissolution. Ii: Enzyme-mediated delivery device. J. Pharmaceutical Sci. 68, 919-921 (1979).
96. Abbott, S., Ralston, J., Reynolds, G. & Hayes, R. Reversible wettability of photoresponsive pyrimidine-coated surfaces. Langmuir 15, 8923-8928 (1999).
97. Ichimura, K., Oh, S.-K. & Nakagawa, M. Light-driven motion of liquids on a photoresponsive surface. Science 288, 1624-1626 (2000).
98. Lin, S.-Y., Lin, Y.-Y. & Chen, K.-S. A thermoswitchable membrane for drug delivery. Drug Deliv. 2, 123-127 (1995).
99. Chen, K.-S., Lin, Y.-Y. & Lin, S.-Y. Thermally on-off switching nylon membrane for controlling drug penetration. Drug Deliv. Syst. 11, 55-61 (1996).
100. Okahata, S., Seki, T. & Yonemori, K. pH-sensitive nylon capsule membranes. Japanese Patent 61025633 (1986).
101. Wilson, M.D. & Whitesides, G.M. The anthranilate amide of 'polyethylene carboxylic acid' shows an exceptionally large change with ph in its wettability by water. J. Am. Chem. Soc. 110, 8718-8719 (1988).
102. Willner, I.I. & Katz, E. Integration of layered redox proteins and conductive supports for bioelectronic applications. Angew. Chem. Int. Ed. Eng. 39, 1180-1218 (2000).
103. Sweedler, J.V., Kuo, T.-C., Cannon, D., Bohn, P.W. & Shannon, M.A. Molecular gates for attoscale preparative separations. in Abstracts of Papers, 222nd American Chemical Society National Meeting, Chicago, Illinois, USA, August 26-30, 2001 ANYL-162 (American Chemical Society, Washington, DC, 2001).
104. Cao, X., Lai, S. & Lee, L.J. Design of a self-regulated drug delivery device. Biomed. Microdevices 3, 109-117 (2001).
105. Umamaheswari, R.B., Jain, P. & Jain, N.K. Hydrogel - a novel drug delivery system. Indian Drugs 39, 243-256 (2002).
106. Mohr, J.M., Schmitt, E.E. & Stewart, R.F. Pulsatile transdermal drug delivery, in Proceedings of the 19th International Symposium on Controlled Release of Bioactive Materials 377-378 (Controlled Release Society, 1992).
107. Kwok, C.S.-K., Ratner, B.D., Mourad, P.D. & Crum, L.A. Polymer-based controlled-release drug delivery devices. US Patent 6444217 (2002).
108. Tran, T.-N. Design of reversible 'smart' surfaces for biomedical and nanotechnological applications. Ph.D. Thesis, Massachusetts Institute of Technology (2003).
109. Lahann, J. et al. A reversibly switching surface. Science 299, 371-374 (2003).
110. Nagakura, T., Ishihara, K., Furukawa, T., Masuda, K. & Tsuda, T. Auto-regulated osmotic pump for insulin therapy by sensing glucose concentration without energy supply. Sens. Actuators B Chem. B34, 229-233 (1996).
111. Kerner, W. Implantable glucose sensors: present status and future developments. Exp. Clin. Endocrinol. Diabetes 109, S341-S346 (2001).
112. Holmstrom, N., Nilsson, P., Carlsten, J. & Bowald, S. Long-term in vivo experience of an electrochemical sensor using the potential step technique for measurement of mixed venous oxygen pressure. Biosens. Bioelectron. 13, 1287-1295 (1998).
113. Mills, P.A. et al. A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J. Appl. Physiol. 88, 1537-1544 (2000).
114. Husak, M. One-chip integrated resonance circuit with a capacitive pressure sensor. J. Micromech. Microeng. 7, 173-178 (1997).
115. English, J.M. & Allen, M.G. Wireless micromachined ceramic pressure sensors. in 12th IEEE International Conference on Micro Electro Mechanical Systems, Technical Digest, Orlando, Florida, USA, January 17-21, 1999 377-378 (IEEE, Piscataway, New Jersey, USA, 1999).
116. Schnakenberg, U. et al. Initial investigations on systems for measuring intraocular pressure. Sens. Actuators A Phys. A85, 287-291 (2000).
117. Schnakenberg, U. et al. Transponder system for non-invasive measurement of intravascular pressure. Biomed. Tech. (Berl.) 47 (Suppl. 1 Pt. 1), 191-193 (2002).
118. Dehennis, A. & Wise, K.D. A double-sided single-chip wireless pressure sensor. in 15th IEEE International Conference on Micro Electro Mechanical Systems, Technical Digest, Las Vegas, Nevada, USA, January 20-24, 2002 252-255 (IEEE, Piscataway, New Jersey, USA, 2002).
119. Schmitz-Rode, T. et al. Vascular capsule for telemetric monitoring of blood pressure. Rofo. Fortschr. Geb. Rontgenstr. Neuen Bildgeb. Verfahr. 175, 282-286 (2003).
120. Allen, M.G. & English, J.M. System, method, and sensors for sensing physical properties. US Patent 6278379, Cont.-in-part of Ser. No. US 1998-54011, filed on 54012 Apr 51998, now (2001).
121. Porat, Y., Penner, A, & Doron, E. Implantable acoustic biosensing system and method. US Patent 6432050 (2002).
122. 2 biofuel cell and its operation in a living plant. J. Am. Chem. Soc. 125, 6588-6594 (2003).
123. Lambert, T.L. et al. Localized arterial wall drug delivery from a polymer-coated removable metallic stent: kinetics, distribution, and bioactivity of forskolin. Circulation 90, 1003-1011 (1994).
124. Lincoff, A.M., Furst, J.G., Ellis, S.G., Tuch, R.J. & Topol, E.J. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J. Am. Coll. Cardiol. 29, 808-816 (1997).
125. Strecker, E.P. et al. Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries. Cardiovasc. Intervent. Radiol. 21, 487-496 (1998).
126. Ahn, Y.K. et al. Preventive effects of the heparin-coated stent on restenosis in the porcine model. Catheter. Cardiovasc. Interv. 48, 324-330 (1999).
127. Grube, E. & Bullesfeld, L. Initial experience with paclitaxel-coated stents. J. Interv. Cardiol. 15, 471-475 (2002).
128. Sonoda, S. et al. Taxol-based eluting stents from theory to human validation: clinical and intravascular ultrasound observations. J. Invasive Cardiol. 15, 109-114 (2003).
129. Renard, E., Costalat, G. & Bringer, J. From external to implantable insulin pump, can we close the loop? Diabetes Metab. 28, 2S19-12S25 (2002).
130. Davis, S.D. et al. Biocompatibility of ceramic implants in soft tissue. J. Biomed. Mater. Res, 6, 425-449 (1972).
131. Herzog, V., Wolf, A., Glauche, R. & Rueckert, D. Coating of polymeric medical implants with silicon nitride or silicon oxide. East German Patent 282391 (1990).
132. Desai, T.A., Ferrari, M. & Mazzoni, G. Silicon microimplants: fabrication and biocompatibility. Mater. Design Technol. 71, 97-103 (1995).
133. Hernandez, P.R. et al. Evaluation of biocompatibility of pH-ISFET materials during long-term subcutaneous implantation. Sens. Actuators B Chem. B46, 133-138 (1998).
134. Hammerle, H. et al. Biostability of micro-photodiode arrays for subretinal implantation. Biomaterials 23, 797-804 (2001).
135. Chow, A.Y. et al. Implantation of silicon chip microphotodiode arrays into the cat subretinal space. IEEE Trans. Neural. Syst. Rehabil. Eng. 9, 86-95 (2001).
136. Voskerician, G. et al. Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials 24, 1959-1967 (2003).
137. Von Recum, A. Handbook of Biomaterials Evaluation: Scientific, Technical, and Clinical Testing of Implant Materials edn. 2 (Taylor & Francis, Philadelphia, USA, 1999).
138. Dee, K.C., Puleo, D.A. & Bizios, R. An Introduction to Tissue-Biomaterial Interactions (Wiley, Hoboken, New Jersey, USA, 2002).
139. Allen, T.M. Stealth liposomes: five years on. J. Liposome Res. 2, 289-305 (1992).
140. Langer, R. Drug delivery and targeting. Nature 392, 5-10 (1998).
141. Wasiewski, W., Fasco, M.J., Martin, B.M., Detwiler, T.C. & Fenton, J.W. Thrombin adsorption to surfaces and prevention with polyethylene glycol 6,000. Thrombosis Res. 8, 881-886 (1976).
142. Blume, G. & Cevc, G. Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta 1029, 91-97 (1990).
143. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2, 347-360 (2003).
144. Shain, W. et al. Controlling cellular reactive responses around neural prosthetic devices using peripheral and local intervention strategies. IEEE Trans. Neural Syst. Rehabil. Eng. 11, 186-188 (2003).